Dermatology · Wichita, KS
NPI
1710915210
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9211 E 21st St N
Wichita, KS, 67206
Phone (316) 609-4558
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
2,613 services
Medicare patients, 2024
787
Average age 77
Drug cost, 2024
$577K
641 prescriptions
Company payments, 2025
$1,017
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stanley L Capper was code 17003 (destruction skin lesion), 897 times for 192 patients. In total Stanley L Capper billed 2,613 services in 42 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 897 | 192 | $4.38 | $3,930 |
| 99213 Office E&M - Established | Office | 671 | 576 | $54.44 | $37K |
| 17000 Destruction Skin Lesion | Office | 300 | 263 | $36.64 | $11K |
| 17110 Destruction Skin Lesion | Office | 239 | 214 | $63.62 | $15K |
| 99214 Office E&M - Established | Office | 120 | 101 | $72.13 | $8,655 |
| 99212 Office E&M - Established | Office | 72 | 71 | $35.97 | $2,590 |
| 99203 Office E&M - New | Office | 54 | 54 | $55.98 | $3,023 |
| 11200 Removal or Shaving of Skin Growth | Office | 32 | 30 | $40.83 | $1,306 |
| 17004 Destruction Skin Lesion | Office | 20 | 18 | $102.21 | $2,044 |
| 17281 Destruction Skin Lesion | Office | 17 | 17 | $118.28 | $2,011 |
| 99204 Office E&M - New | Office | 16 | 16 | $82.67 | $1,323 |
| 99202 Office E&M - New | Office | 15 | 15 | $47.11 | $707 |
| 17261 Destruction Skin Lesion | Office | 15 | 11 | $83.00 | $1,245 |
By year: 2022 $127K for 3,773 services; 2023 $130K for 3,592 services; 2024 $97K for 2,613 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stanley L Capper prescribed most often to Medicare patients was Triamcinolone Acetonide, with 146 prescriptions and refills. In total Stanley L Capper wrote 641 Medicare prescriptions that cost $577K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 146 | 160 | 84 | $1,061 |
| Hydroxyzine Hcl Generic | 75 | 118 | 39 | $895 |
| Amoxicillin Generic | 52 | 62 | 18 | $489 |
| Cephalexin Generic | 50 | 52 | 34 | $499 |
| Clobetasol Propionate Generic | 41 | 42 | 27 | $1,854 |
| Doxycycline Hyclate Generic | 32 | 42 | 16 | $931 |
| Humira(Cf) Pen Adalimumab | 22 | 22 | Under 11 | $211K |
| Hydroxychloroquine Sulfate Generic | 16 | 30 | Under 11 | $622 |
| Sotyktu Deucravacitinib | 16 | 24 | Under 11 | $151K |
| Mupirocin Generic | 16 | 16 | Under 11 | $100 |
| Ketoconazole Generic | 15 | 16 | 11 | $439 |
| Tacrolimus Generic | 11 | 11 | Under 11 | $1,048 |
Brand drugs: 62 claims; generic drugs: 579 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stanley L Capper $1,017 ($1,017 in general payments such as food, travel and fees) from 11 companies. The largest payer was Janssen Biotech, Inc. with $302.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 12 | $302 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $144 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $139 |
| Amgen Inc. AMGN | 6 | $116 |
| Abbvie Inc. ABBV | 3 | $60.73 |
| Lilly USA, LLC LLY | 3 | $59.35 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $59.23 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $47.37 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $36.71 |
| UCB, Inc. UCB.BR | 1 | $31.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.